Allo, Erlyn G.
HRN: 12-42-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2023
CEFTRIAXONE 1G (VIAL)
04/21/2023
04/28/2023
IV
1gm
OD
UTI
Waiting Final Action
Indication: EmpiricEmpiric Then Culture-directed Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes